Back to search

Article

Hematopoietic Tet2 inactivation enhances the response to checkpoint blockade immunotherapy

2024-09-11

Abstract excerpt

<h4>ABSTRACT</h4> Somatic mutations inactivating TET2 are among the most common drivers of clonal hematopoiesis (CH). While TET2 inactivation is associated with monocyte-derived inflammation and improved chimeric antigen-receptor-T cell function, its impact on immunotherapy response is unknown. In our mouse model, hematopoietic Tet2 mutation enhanced immune checkpoint blockade (ICB) response. Enhanced ICB respo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3cf27de1-40c1-5318-8686-965f141f4468
DOI
10.1101/2024.09.09.612140
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hematopoietic Tet2 inactivation enhances the response to checkpoint blockade immunotherapyDOI 10.1101/2024.09.09.612140
Select a neighboring publication to make it the new centre.